Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
News 6/22/2011 - Bye Bye Shorts! (LINK)
http://finance.yahoo.com/news/Axcelis-Celebrates-Shipment-pz-1568077654.html?x=0&.v=1
ACLS Website UPDATED TODAY with LOTS of New Jobs (LINK)
This will pop hard and strong. Hang on to your shares longs...see the new job openings just posted!!!
http://www.axceliscareers.com/search.asp (click Search Jobs and watch what comes up!)
This High-Tech Value Stock Could Jump 150% or More (LINK - NEWS JUST OUT!)
http://www.streetauthority.com/a/high-tech-value-stock-could-jump-150-or-more-458261
Going to be a nice day tomorrow!
This is why we are UP today and will head on to $2.50 and above
ACLS nice news..(COMTEX) B: Axcelis Technologies is Going Back in the Black as Positive Ea
rnings Are Now Expected (ACLS) ( Comtex SmarTrend(R) )
B: Axcelis Technologies is Going Back in the Black as Positive Earnings Are Now
Expected (ACLS) ( Comtex SmarTrend(R) )
May 04, 2011 (SmarTrend(R) News Watch via COMTEX) --
Axcelis Technologies (NASDAQ:ACLS), which was in the red a year ago, is
expected to turn a profit this year according to analyst expectations.
In the last fiscal year, the company lost $0.19 per share. Axcelis
Technologies is now estimated to attain profitability and earn $0.17 per
share this year, based on 106.0 million shares outstanding.
Axcelis Technologies is currently trading below its 50-day moving average of
$2.48 and trading below its 200-day moving average of $2.40.
SmarTrend currently has shares of Axcelis Technologies in an Downtrend and
issued the Downtrend alert on February 02, 2011 at $2.86. The stock has
fallen 38.5% since the Downtrend alert was issued.
Write to Chip Brian at cbrian@mysmartrend.com
Wait until 9:30 and watch this baby go to $2.50. When this kind of move happens with huge premarket buying, it's something big - like a buy out or new customer, etc.
ACLS - Wait until 9:30 and watch this baby go to $2.50. When this kind of move happens with huge premarket buying, it's something big - like a buy out or new customer, etc.
Something BIG is happening! UP 17% and more premarket!
NEWS - today - Look for Axcelis to REBOUND
http://www.zacks.com/research/get_news.php?id=119l3045
matt24d - can you send me your email. bittymack@yahoo.com - want to private message you but don't have the higher subscription on here.
Tks.
INSIDERS buying:
http://www.bizjournals.com/boston/news/2011/02/04/axcelis-execs-are-buyers-after-stock.html?ana=yfcpc
Same thing happened last quarter and the stock recovered the next day.
Insiders have purchased over 6,000,000 dollars worth of KITD recently
Link for proof:
http://www.fool.com/investing/general/2011/03/08/insiders-vs-short-sellers-highly-shorted-stocks-ba.aspx
Scroll down on the link above and read about KITD (here is what it says):
"Insiders have purchased 592,770 shares over the last six months (an increase of 9.5%)"
They have over 1,200 clients. Go to their website and see their introduction. Some of their big clients are below: Look at their website and learn about the company with their video http://kitd.com/company/about-us/
Nasdaq
Google
NewsCorp
Verizon
At&t
the Associated Press
GM
Vodafone
MSN
GE
Yahoo
Sony
Reuters
NY Post
Auto trader
and many many more
NEW ARTICLE 4/12 11:50 AM - just out BULLISH!
http://www.thestreet.com/story/11079788/1/community-health-systems-stock-gaps-up-on-todays-open-cyh.html
"CYH remains committed to its offer to acquire Tenet and both Credit Suisse and Goldman Sachs have reaffirmed their confidence in financing the transaction.”
Here is the link to confirm:
http://ih.advfn.com/p.php?pid=nmona&article=47250541
AND more news: http://www.thelion.com/bin/forum.cgi?tf=wall_street_pit&msg=2114455&cmd=r&t=
NEWS! http://www.marketwatch.com/story/hospital-stocks-climb-back-after-big-selloff-2011-04-12?siteid=yhoof
"Skepticism among Wall Street analysts about Tenet’s charges seemed to take root as both Community and Tenet shares started to climb back after incurring heavy losses on Monday.
Tenet is trying to fend off Community’s $6-a-share hostile takeover bid, and has put off its 2011 annual meeting along with adopting a “poison pill” shareholder rights plan. While some analysts cut Community’s ratings on Monday and early Tuesday, several were skeptical that Tenet’s charges would stick."
Volume has been huge the past week! News is leaking
Partnership will be announced any day!!!!
STRONG BUY!
More News 3/28
http://www.cnanalyst.com/2011/03/top-10-pharmaceutical-stocks-with-highest-upside-mrna-alxa-cxm-dara-cycc-cytr-pip-avnr-gnvc-cbp-mar-.html
"Alexza Pharmaceuticals, Inc. (NASDAQ:ALXA) has the 2nd highest upside potential in this segment of the market. Its upside is 294.7%. Its consensus target price is $6.00 based on the average of all estimates."
Another article just out 3/21 - strong buy (link)
http://latestbusiness-news.com/in-focus-the-sizzling-sector-of-the-day-pran-alxa-and-cbrx-117017.html?utm_source=twitterfeed&utm_medium=twitter
Also, twitter is going crazy today talking about ALXA
Have a great night longs!
ALXA has 300% upside Potential - LINK from today
http://www.nasd100.com/2011/03/top-small-cap-stocks-with-highest-upside-potential-mar-21-2011.html
Upcoming catalysts that will move the stock to around $3:
There are two possible approvals, one here in the US and one overseas.
Here is the timeline:
Partnership which can happen any time within the next 60 days, filing in the US, acceptance of filing, file in Europe.
(ALXA has more going for itself this time with also filing in Europe, which everyone knows is easier to get approval.) Stocks will increase 100% on Europe approval alone!
FDA did NOT ask for another study and the CRL is a stage 2.
The issue with FEV1 that came up in 10% of individuals was in the Phase 1 trail ONLY - not phase 3!
Partnership now open to worldwide rights instead of just US
King made it very clear on the conf. call that the partnership would alleviate having to dilute.
We have been upgraded by a few and T.Rowe Price is now a very large shareholder in the company.
Now, we just sit back and wait for the upcoming news.
They always file late and file within the 15 days allotted. Here is the proof:
http://sec.gov/cgi-bin/browse-edgar?company=home+system+group&match=&CIK=&filenum=&State=&Country=&SIC=&owner=exclude&Find=Find+Companies&action=getcompany
seekingalpha.com/article/258613-all-eyes-on-alexza-as-company-prepares-to-re-file-drug-application
The best thing I took out of this extension filing was that the below question was a yes, no, question and they checked NO. So, that is good news.
"Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?"
Upgraded TODAY 3/16/2011 (Link attached as proof)
Zack's analyst Jason Napodano upgraded Alexa today to Outperform with $3 target.
http://twitter.com/JNapodano
"$ALXA Upgraded to Outperform. New target is $3."
"I see a number of catalysts in 2011, prior to the actual FDA PDUFA date in Jan 2012. At $1.18 (yst. close) I like the r/r."
Here is some of the wording from the report:
We are upgrading our rating on shares of Alexza to
Outperform and raising our price target to $3 per share.
We believe the company is on track to re-file the new drug
application (NDA) on AZ-004 (Staccato loxapine) for the
treatment of acute agitation in patients with schizophrenia or
bipolar disorder by the end of July 2011. Based on our
analysis of the complete response letter (CRL) received on
October 8, 2010, and our numerous conversations with
management, we believe Alexza is adequately prepared to file
a full response with an excellent chance to receive approval in
January 2012. We see multiple catalysts in 2011, including
the NDA filing, an FDA panel review, and a potential deal for
AZ-004 commercialization, prior to the FDA s decision in early
2012 as opportunities to drive the shares toward our target.
Love the facebook page for MSLP:
http://www.facebook.com/home.php#!/musclepharm
"Filing Sends Radient Shares Higher" LINK! NEWS!
Here is link:
http://www.baystreet.ca/users/newswire/viewarticle.aspx?id=391580
Here are the words:
02/14/2011 [ACCESSWIRE]
Shares of Radient Pharmaceuticals (AMEX:RPC) rose 13% on Monday following a disclosure from Heights Capital Management that Capital Ventures International had recently taken a 5.7% stake in the company.
In a statement filed with the SEC; via Schedule 13G; it was noted that the same firm who is noted as an early investor in Dendreon Corporation (Nadaq:DNDN) took a large position in the company.
By filing a Form 13G, a party discloses that it own between 5% and 20% in the company. It must also be clearly understood that the party acquiring the stake in the company is only a passive investor, and does not intend to exert control.
In addition, the Comtex News SmarTrend system, which analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time, noted that shares of the company might be set for a rebound.
Upcoming catalysts in the stock include results from a major validation study being conducted with the Mayo Clinic. Positive clinical data from that study, which will compare Radient's early cancer detection technology against current testing methods, could send shares significantly higher.
Radient Pharmaceuticals engages in the research, development, manufacture, and marketing of diagnostic and skin care products. It offers ONKO-SURE, a proprietary in-vitro diagnostic cancer test, which is used for the detection and/or monitoring of lung, breast, stomach, liver, colon, rectal, ovarian, esophageal, cervical, trophoblastic, thyroid, malignant lymphoma, and pancreatic cancers.
Wow! Impressive News! Took at almost 6% stake in RPC. Their last move was Dendreon Corporation and well, you know that skyrocketed. Nice!
You mean "Goldseeker" on ignore?
I am sick of all of his BS. If he has no position in the stock, no need for him to be here. Moderator - can you get him off? He actually does have a position in this stock - short or he is wanting to get in. Today he will be disappointed. We will be green today.
Wrong - CEA test is a 300 million market cap and Onko-Sure is a better indicator. Once Mayo Clinic results are out - watch the orders and press come in. You are obviously short - you aren't here for your health. Give it a rest already. The squeeze is about to take hold. We go green today.
FDA approved the test - bottom line - and they don't just approve something that doesn't have value in the marketplace. It is very hard to get any approvals from the FDA and most do not succeed.
I see that
Biomed Just Tweeted that News is Coming - FYI
http://twitter.com/BioMedReports
I would be happy to provide each email Garza sent to me. I will save them. :) Oh, I will also save the ones he sent me today. He is only passing on information that an informant gave him. So, anything Garza has said is based on someone else saying it. It would be best for Garza or the informant to just come out and do an article on what they believe is happening.
I can take a picture of my email. I am just passing on the exact information he gave me. I am not in the stock anymore as there was another stock I just couldn't pass up today. But, congrats to the longs for holding this. Good luck to you and hope this news gets printed so everyone can confirm it. Hopefully you will hear from RPC with great news. Since there is a source talking with GARZA and he doesn't want most to know...that information will be out shortly. Leaving for the day - good luck to you all!
Copied from my email - done with this now - just wait and see THIS IS EVERYTHING WORD FOR WORD GARZA WROTE - NOTHING TAKEN OUT OR CHANGED. My questions I didn't bother copying - just read from the bottom up. He doesn't want the word out yet, but why not give it to the longs to celebrate? I no longer own a position in the stock and am stuck in something else I just couldn't pass up today...but I can definitely share this good news for you.
____________________________________
From: garza@biomedreports.com [mailto:garza@biomedreports.com]
Sent: Monday, February 07, 2011 12:23 PM
To:
Subject: RE: What is this about???
Because you communicated with me in the past, and I thought I could trust you. Geez! Now it's my fault?
From: garza@biomedreports.com [mailto:garza@biomedreports.com]
Sent: Monday, February 07, 2011 12:11 PM
To:
Subject: RE: What is this about???
Because it EXPOSES my source!
From: garza@biomedreports.com [mailto:garza@biomedreports.com]
Sent: Monday, February 07, 2011 12:07 PM
To:
Subject: RE: What is this about???
What part of "Between you and me.." made you think that?
From: garza@biomedreports.com [mailto:garza@biomedreports.com]
Sent: Friday, February 04, 2011 4:30 PM
To:
Subject: RE: RPC - Article just out
Absolutely. I think it will be around the Mayo results, but there could be more news. Yes.. I am VERY MUCH long.
I also believe the company is working on a 3rd- not previously discussed- spin-off involving cancer detection for pets. That's a HUGE under served market.
From: garza@biomedreports.com [mailto:garza@biomedreports.com]
Sent: Friday, February 04, 2011 4:18 PM
To:
Subject: RE: RPC - Article just out
Between you and me (please), I understand that the company may be planning a major press conference.
From: garza@biomedreports.com [mailto:garza@biomedreports.com]
Sent: Friday, February 04, 2011 4:18 PM
To:
Subject: RE: RPC - Article just out
EASILY!
Also, can you see this stock reaching $1 again?
From: garza@biomedreports.com [mailto:garza@biomedreports.com]
Sent: Friday, February 04, 2011 2:15 PM
To:
Cc: info@biomedreports.com
Subject: RE: RPC - Article just out
We apppreciate your enthusiasm for the article. Feel free to spread it around. Our syndicators will soon pick it up too.
Also.. Know that big news is coming. We remain bullish on the stock.
I am the one he emailed and it is 100% true. I have the emails from him to prove it and also the one YOU sent him that he forwarded to me asking why I put this on the message board. Here is what I got from him today:
Garza: "What is this about?"
Sorry to take up your time but someone posted this in a forum and I wanted to confirm it.
I emailed Garza with Biomed and here is what he told me word for word (Garza response in quotes):
"Between you and me (please), I understand that the company may be planning a major press conference."
(I asked him if he thought the stock price would reach $1)
"EASILY - Absolutely. I think it will be around the Mayo results, but there could be more news. Yes.. I am VERY MUCH long.
I also believe the company is working on a 3rd- not previously discussed- spin-off involving cancer detection for pets. That's a HUGE under served market."
ME: "Sorry! Thought you would want this told."
GARZA: "What part of "Between you and me.." made you think that? Because it EXPOSES my source!"
M.E. Garza
BioMedReports.Com
END OF CONVERSATION TODAY. Wait and see - if you are long in the stock and you trust Garza - see what happens.
I emailed GARZA with BioMed-BULLISH! Here is what he said!
I emailed Garza with Biomed and here is what he told me word for word (Garza response in quotes):
"Between you and me (please), I understand that the company may be planning a major press conference."
(I asked him if he thought the stock price would reach $1)
"EASILY - Absolutely. I think it will be around the Mayo results, but there could be more news. Yes.. I am VERY MUCH long.
I also believe the company is working on a 3rd- not previously discussed- spin-off involving cancer detection for pets. That's a HUGE under served market."
"Also.. Know that big news is coming. We remain bullish on the stock."
Feel free to email him yourself. Go to the biomed website and contact Garza - his email is right there.
Good luck all - Going to $1 and beyond!
LINK to NEW 1:40 PM Today - GOING TO CLOSE GREEN
http://biomedreports.com/2011020463305/radient-pharmaceuticals-bullish-or-bullcrap.html
News 12:16 PM today! From RPC - REF: Adam F's blog today!
We are fully aware of the story and I am working with my scientific and leadership teams with regards to a response. This reporter is notorious for publishing less than ethical news -- we declined to interview with him for that very reason. Stay tuned and thanks for your support of RPC. We are diligently working our strategic plan and will not get derailed by this type of publicity.
Kristine
Kristine M. Szarkowitz
Investor Relations Director
Radient Pharmaceuticals
(Direct:) 206.310.5323
kszarkowitz@amdl.com
www.radient-pharma.com